RedHill Biopharma's Talicia® Gains FDA Approval for 5-Year U.S. Market Exclusivity with IP Protection Through 2034.
Share this post
This Biopharmaceutical Company Just Secured…
Share this post
RedHill Biopharma's Talicia® Gains FDA Approval for 5-Year U.S. Market Exclusivity with IP Protection Through 2034.